There is 1 paper on treatment-related myeloid malignancy in aging research: 1 observational study in people. The newest story, Nov 2, 2026: “Blood-cell clones linked to complications after lymphoma therapy”.
1 paper studies it1 finding
1 new paper in 30 daysSee all 1 papers on treatment-related myeloid malignancy
“Clonal hematopoiesis (CH) commonly expanded following CAR19 infusion and was associated with impaired immune reconstitution and treatment-related myeloid malignancy (tMN).”
Clonal hematopoiesis
upin humans1
Clonal hematopoiesis is associated with treatment-related myeloid malignancy in humans Following CAR19 therapy in patients with lymphoma.
“Clonal hematopoiesis (CH) commonly expanded following CAR19 infusion and was associated with impaired immune reconstitution and treatment-related myeloid malignancy (tMN).”
HumansFollowing CAR19 therapy in patients with lymphoma
Blood-cell clones linked to complications after lymphoma therapy
Nature genetics
An observational study in patients with lymphoma linked expanding blood-cell clones to poorer immune recovery and treatment-related blood cancers after engineered…An observational study in patients with lymphoma linked expanding blood-cell clones to poorer immune recovery and treatment-related blood cancers after engineered immune-cell therapy.